Kimberley Ramsey | Business Development Manager
PathoQuest

Kimberley Ramsey, Business Development Manager, PathoQuest

With more than 15 years of commercial experience in the global Life Sciences industry, Kimberley brings deep expertise in biosafety testing for Cell and Gene Therapy (CGT), Biologics, and Vaccine manufacturing. As the Business Development Manager at PathoQuest SAS, she leads partnerships across the UK, Netherlands, and Asia-Pacific, driving the adoption of GMP-compliant Next Generation Sequencing (NGS) to support the development of advanced therapeutic modalities. Kimberley holds a Bachelor of Science from Saint Mary’s College, and has a strong track record of connecting cutting-edge technologies with the evolving needs of biopharmaceutical manufacturers.
 

Appearances:



Day 1 - Tuesday 14th October @ 14:30

QC Testing with GMP Next Generation Sequencing (NGS) for Vaccine Release

Session led by: PathoQuest
last published: 04/Sep/25 14:25 GMT

back to speakers

Get involved at World Vaccine Congress Europe 2025

 

 

TO SPONSOR


Christian Larsmon

Christian.Larsmon@terrapinn.com

 

Otto Squire
Otto.Squire@terrapinn.com

 

TO SPEAK


Isla Sutherland

Isla.Sutherland@terrapinn.com

 

MARKETING & PRESS


Jasper Cameron

Jasper.Cameron@terrapinn.com

 

Stay Up-to-Date

Join our mailing list to receive exclusive content and offers.

By submitting, you agree to receive email communications from Terrapinn, including upcoming promotions and discounted tickets and news.